<DOC>
	<DOCNO>NCT01799824</DOCNO>
	<brief_summary>The purpose study confirm effect ANT-1403 treatment primary axillary hyperhidrosis .</brief_summary>
	<brief_title>Clinical Trial Evaluate ANT-1403 Treatment Primary Axillary Hyperhidrosis</brief_title>
	<detailed_description />
	<mesh_term>Hyperhidrosis</mesh_term>
	<criteria>age 18 70 year age diagnosis moderate severe primary axillary hyperhidrosis ≥50 mg sweat production/axilla 5 minute measure gravimetrically HDSS score ≥3 diagnosis secondary hyperhidrosis skin affliction axilla require medical treatment 20 % aluminum hydrochloride , e.g . Drysol® , 2 week prior Baseline oral anticholinergic treatment botulinum toxin treatment prior 9 month history surgery axillary hyperhidrosis present history neuromuscular disease female subject pregnant nursing child</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>